Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 3Vaginitis 1Urologic Neoplasms 1Urologic Diseases 1Sexuality 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Hypogonadism 1Dyspareunia 1Castration-Resistant Prostate Carcinoma 1

Interventions

Psychiatric Rehabilitation 4Counseling 4Sildenafil Citrate 2Radiotherapy 2High-Intensity Focused Ultrasound Ablation 2Exercise 2methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Vitamin E 1Vitamin D 1Testosterone Propionate 1Testosterone 1Tadalafil 1Sexual Health 1Sex Education 1Robotics 1Restraint, Physical 1Radiosurgery 1Quality of Life 1Prostatectomy 1Pilocarpine 1Phenylephrine 1Phentolamine 1Papaverine 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Menogaril 1Magnetic Resonance Spectroscopy 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sexual Dysfunction, Physiological × Testosterone Propionate × Clear all
NCT00075855 2016-07-13

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Alliance for Clinical Trials in Oncology

Phase 3 Completed
150 enrolled
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡